Laddar...
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunotherapy resistance is a major challenge for B-cell lymphoma treatment. To overcome this issue, combinatorial therapeutic strategies have been pursued to achieve a better e...
Sparad:
| I publikationen: | Protein Cell |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Higher Education Press
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305292/ https://ncbi.nlm.nih.gov/pubmed/32162275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13238-020-00694-x |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|